中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Synthesis and biological evaluation of SGLT2 inhibitors: gem-difluoromethylenated Dapagliflozin analogs

文献类型:期刊论文

作者Chen ZH(陈增浩) ; Wang RW(王若文) ; Qing FL(卿凤翎)
刊名Tetrahedron Lett.
出版日期2012
卷号53期号:17页码:2171-2176
ISSN号0040-4039
其他题名SGLT2抑制剂的合成和生物评价: gem-二氟亚甲基Dapagliflozin类似物
通讯作者卿凤翎
英文摘要Dapagliflozin is currently the most advanced SGLT2 inhibitor, which has been used in Phase III clinical trials for treatment of diabetes. Here we describe the design and synthesis of Dapagliflozin analogs modified with gem-difluoromethylene group. Their biological evaluation of in vitro inhibitory activity against human SGLT2 showed that some of the analogs with CF2 at C-4 are better SGLT2 inhibitors compared with Dapagliflozin. (c) 2012 Elsevier Ltd. All rights reserved.
学科主题氟化学
收录类别SCI
原文出处http://dx.doi.org/10.1016/j.tetlet.2012.02.062
语种英语
WOS记录号WOS:000302587800007
公开日期2013-08-23
源URL[http://202.127.28.38/handle/331003/28249]  
专题上海有机化学研究所_中科院有机氟化学重点实验室
推荐引用方式
GB/T 7714
Chen ZH,Wang RW,Qing FL. Synthesis and biological evaluation of SGLT2 inhibitors: gem-difluoromethylenated Dapagliflozin analogs[J]. Tetrahedron Lett.,2012,53(17):2171-2176.
APA 陈增浩,王若文,&卿凤翎.(2012).Synthesis and biological evaluation of SGLT2 inhibitors: gem-difluoromethylenated Dapagliflozin analogs.Tetrahedron Lett.,53(17),2171-2176.
MLA 陈增浩,et al."Synthesis and biological evaluation of SGLT2 inhibitors: gem-difluoromethylenated Dapagliflozin analogs".Tetrahedron Lett. 53.17(2012):2171-2176.

入库方式: OAI收割

来源:上海有机化学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。